London Stock Exchange Welcomes Verici Dx plc to AIM


London Stock Exchange welcomes Verici Dx plc (‘Verici Dx’ or the ‘Company’), a developer of advanced clinical diagnostics for organ transplant, to celebrate the listing of the Company's public shares onto AIM, under the ticker "VRCI".

Verici Dx is an immuno-diagnostics development company, initially focused on the kidney transplantation market. The Company's kidney transplant assays will use advanced next-generation sequencing that may define a personalised risk profile of each patient over the course of their transplant journey and may also detect injury in advance of currently available clinical tests.

The Company develops tests to understand how a patient is likely to, and may be, responding to kidney transplant. There are two leading products for clinical validation and commercialisation:

•    Clarava™, which is a pre-transplant prognosis for the risk of early acute rejection; and
•    Tuteva™, a post-transplant diagnostic focused upon acute cellular rejection, including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatinine levels.

Verici Dx raised £14.5m gross significantly oversubscribed fundraising with net proceeds being used to undertake clinical utility and validation studies, to bioinformatics and health economic studies as well as staff and related benefits, for general corporate overheads and for license and royalties and capital expenditure (including to build additional testing capacity).

Sara Barrington, CEO of Verici Dx, said: “We are very grateful for the strong support shown by institutional and other investors to the Verici Dx IPO.  Obtaining funding in a public market is a strong signal of quality to prospective partners and customers, raises the profile of the business and its innovative products considerably, and gives us a supportive platform as we advance our strategy.  We look forward to providing further updates on the execution of our validation and commercialisation plans as we deploy the capital raised towards addressing a significant unmet clinical need.”

To find out more about Verici Dx visit:  www.vericidx.com

Quick facts

Track
Market: AIM
Instrument market cap (£m)
104.18
Listing/Admission to trading
03 Nov 2020
Looking for new and recent issues?

More recent

London Stock Exchange today welcomes Softline to Main Market

London Stock Exchange today welcomes Softline, a leading global solutions and services provider in digital transformation and cybersecurity, to the Standard Segment of the Main Market of London Stock Exchange trading under the ticker symbol SFTL.

Softline's objective is to help improve business performance and quality of life through the most effective use o

Learn more
London Stock Exchange Welcomes Invesco celebrating the launch of Nasdaq-100 ESG UCITS ETF

Today, London Stock Exchange welcomes Invesco for the newest addition to the Invesco Nasdaq Innovation Suite, a new Environmental, Social and Governance (ESG) ETF: the Invesco Nasdaq-100 ESG UCITS ETF.

The Nasdaq-100 index has long been associated with growth and innovation, including many of today’s leading-edge companies, such as Apple, Amazon, Netflix and

Learn more
36.52
London Stock Exchange welcomes Tungsten West to AIM

Tungsten West Plc (“Tungsten West” or “the Company”) is a UK based company focussed on recommencing production at the Hemerdon tungsten and tin mine (“Hemerdon” or the “Project”) in Devon, England.

The Hemerdon mine is the world’s third largest Tungsten resource, had over £170m spent on it via the previous operator and has a mine life of 18.5 years. The Company is focused on rebuildin

Learn more
139.92
London Stock Exchange welcomes the Republic of Korea’s Sovereign Green Bond to the Sustainable Bond Market

London Stock Exchange today welcomes the Republic of Korea issuing their €700mn -0.053% note due October 2026 to London Stock Exchange’s International Securities Market. The deal was more than 6 times oversubscribed, receiving bids in excess of €4.2bn from over 150 accounts.

The €700mn 5-year tranche is Korea’s debut green bond and it was admitted yesterday to our Sustainable Bond Mar

Learn more